LAmB has usually been recommended for febrile or neutropenic patients resulting from fungal infections such as aspergillosis, candidiasis, and cryptococcosis and those that are refractory to AmB deoxycholate (Seibel Nita et al., 2017). This evidence concerns the gene GRAMD1B and aspergillosis.